Print

Cynosure, Inc. (CYNO) to Present at Canaccord Genuity 33rd Annual Growth Conference  
8/5/2013 6:58:47 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WESTFORD, Mass., August 5, 2013 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO) today announced that its senior management will present at the Canaccord Genuity 33rd Annual Growth Conference at 8:00 a.m. (ET) on Wednesday, August 14 in Boston.

The presentation by Cynosure Chairman and Chief Executive Officer Michael Davin and Executive Vice President, Chief Operating Officer and Chief Financial Officer Timothy Baker will be available via live and archived audio webcast accessible through a link on the Investor Relations section of the Company's website, www.cynosure.com.

About Cynosure, Inc.
Cynosure develops and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, liquefy and remove unwanted fat through laser lipolysis, reduce cellulite, treat toe fungus and ablate sweat glands. Cynosure's product portfolio is composed of a broad range of energy sources including Alexandrite, diode, Nd: YAG, picosecond, pulse dye, Q-switched lasers and intense pulsed light. Cynosure sells its products globally under the Cynosure, Palomar and ConBio brand names through a direct sales force in the United States, Canada, Mexico, France, Germany, Spain, the United Kingdom, Australia, China, Japan and Korea, and through international distributors in approximately 100 other countries. For corporate or product information, visit Cynosure's website at www.cynosure.com.

Contact:
Scott Solomon
Vice President
Sharon Merrill Associates, Inc.
617-542-5300
cyno@investorrelations.com

SOURCE Cynosure, Inc.



Help employers find you! Check out all the jobs and post your resume.

//-->